Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction

This publication has 32 references indexed in Scilit:

• Type-Specific Persistence of Human Papillomavirus DNA before the Development of Invasive Cervical Cancer
  New England Journal of Medicine, 1999
• Seroreactivity to Human Papillomavirus Types 16, 18, 31, and 45 Virus‐Like Particles in a Case‐Control Study of Cervical Squamous Intraepithelial Lesions
  The Journal of Infectious Diseases, 1999
• Seropositivities to Human Papillomavirus Types 16, 18, or 33 Capsids and to Chlamydia trachomatis Are Markers of Sexual Behavior
  The Journal of Infectious Diseases, 1996
• Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer.
  Journal of Clinical Pathology, 1995
• Serologic Response to Human Papillomavirus Type 16 (HPV-16) Virus-like Particles in HPV-16 DNA-Positive Invasive Cervical Cancer and Cervical Intraepithelial Neoplasia Grade III Patients and Controls from Colombia and Spain
  The Journal of Infectious Diseases, 1995
• Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer
  International Journal of Cancer, 1995
• Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix
  The Lancet, 1994
• Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial Neoplasia
  JNCI Journal of the National Cancer Institute, 1993
• Human Papillomavirus Infection of the Cervix
  Obstetrics & Gynecology, 1992
• Meta-analysis in clinical trials
  Controlled Clinical Trials, 1986